miR-19a has been shown to be involved in coronary microvascular obstruction injury; however, the underlying molecular mechanisms remain unknown. In our study, we tried to explore the role of miR-19a in cardiomyocyte apoptosis and calcium overload in vivo and in vitro induced by hypoxia. We established the acute myocardial infarction (AMI) rat model by ligating the left anterior descending artery. The expression of miR-19a in the infarct zone of AMI rats and myocardial tissue in the same position in sham rats was analyzed using RT-qPCR while Na /H exchanger 1 (NHE-1) was detected by Western blotting. We also observed the effects of overexpressing miR-19a or administering an NHE-1 inhibitor (cariporide) on hypoxia-induced (HI) calcium overload and apoptosis in primary cardiomyocytes. In addition, dual-luciferase reporter assays were conducted to investigate the potential target of miR-19a on NHE-1. Decreased miR-19a expression, as well as increased apoptosis and NHE-1 expression, were observed in the AMI model. Furthermore, after hypoxia stimulation, miR-19a was gradually reduced as time increased in primary cardiomyocytes. Overexpressing miR-19a using mimics ameliorated the increase in NHE-1 in hypoxic cardiomyocytes and thereby reduced the HI cell calcium overload and cell apoptosis rate from 12.32% to 9.5% (P < .01). In addition, the dual-luciferase reporter gene assay results verified that NHE-1 was the direct target of miR-19a. Our findings suggest that miR-19a activation can attenuate HI cardiomyocyte apoptosis by downregulating NHE-1 expression and decreasing calcium overload.
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388(10053):1603-1658. https://doi.org/10.1016/S0140-6736(16)31460-X
Wan X, Ren H, Ma E, Yang G. Mortality trends for ischemic heart disease in China: an analysis of 102 continuous disease surveillance points from 1991 to 2009. BMC Public Health. 2017;18(1):52. https://doi.org/10.1186/s12889-017-4558-3 [Journal Article].
Bartel DP. MicroRNAs. Cell. 2004;116(2):281-297.
Hang P, Sun C, Guo J, Zhao J, Du Z. BDNF-mediates downregulation of microRNA-195 inhibits ischemic cardiac apoptosis in rats. Int J Biol Sci. 2016;12(8):979-989. https://doi.org/10.7150/ijbs.15071
Xu H, Cao H, Zhu G, Liu S, Li H. Overexpression of microRNA-145 protects against rat myocardial infarction through targeting PDCD4. Am J Transl Res. 2017;9(11):5003-5011.
Paiva S, Agbulut O. MiRroring the multiple potentials of microRNAs in acute myocardial infarction. Front Cardiovasc Med. 2017;4:73. https://doi.org/10.3389/fcvm.2017.00073
Qiu R, Li W, Liu Y. MicroRNA-204 protects H9C2 cells against hypoxia/reoxygenation-induced injury through regulating SIRT1-mediated autophagy. Biomedicine & Pharmacotherapy. 2018;100:15-19. https://doi.org/10.1016/j.biopha.2018.01.165
Li Y, Du Y, Cao J, et al. MiR-130a inhibition protects rat cardiac myocytes from hypoxia-triggered apoptosis by targeting Smad4. Kardiol Pol. 2018;76(6):993-1001. https://doi.org/10.5603/KP.a2018.0040.
Martinez EC, Lilyanna S, Wang P, et al. MicroRNA-31 promotes adverse cardiac remodeling and dysfunction in ischemic heart disease. J Mol Cell Cardiol. 2017;112:27-39. https://doi.org/10.1016/j.yjmcc.2017.08.013
Chen Q, Guo W, Zhang Y, Wu Y, Xiang J. MiR-19a promotes cell proliferation and invasion by targeting RhoB in human glioma cells. Neurosci Lett. 2016;628:161-166. https://doi.org/10.1016/j.neulet.2016.06.031
Zhang X, Chen Y, Zhao P, et al. MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma. Leukemia & Lymphoma. 2017;58(4):932-940. https://doi.org/10.1080/10428194.2016.1213827
Sun G, Lu Y, Li Y, et al. miR-19a protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis via PTEN/PI3K/p-Akt pathway. Biosci Rep. 2017;37(6):BSR20170899. https://doi.org/10.1042/BSR20170899
Gao Y, Qian J, Chen Z, et al. Suppression of Bim by microRNA-19a may protect cardiomyocytes against hypoxia-induced cell death via autophagy activationToxicol Lett. 2016;257:72-83. https://doi.org/10.1016/j.toxlet.2016.05.019
Eckle T, Grenz A, Köhler D, et al. Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am J Physiol Heart Circ Physiol. 2006;291(5):H2533-H2540. https://doi.org/10.1152/ajpheart.00472.2006
Simpson P, Savion S. Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol. Circ Res. 1982;50(1):101-116.
Sun HY, Wang NP, Halkos ME, et al. Involvement of Na+/H+ exchanger in hypoxia/reoxygenation-induced neonatal rat cardiomyocyte apoptosis. Eur J Pharmacol. 2004;486(2):121-131. https://doi.org/10.1016/j.ejphar.2003.12.016
Yao LL, Huang XW, Wang YG, et al. Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3β-dependent opening of mPTP. Am J Physiol Heart Circ Physiol. 2010;298(5):H1310-H1319. https://doi.org/10.1152/ajpheart.00339.2009
Fliegel L. Regulation of the Na(+)/H(+) exchanger in the healthy and diseased myocardium. Expert Opin Ther Targets. 2009;13(1):55-68. https://doi.org/10.1517/14728220802600707
Kintner DB, Chen X, Currie J, et al. Excessive Na+/H+ exchange in disruption of dendritic Na+ and Ca2+ homeostasis and mitochondrial dysfunction following in vitro ischemia. J Biol Chem. 2010;285(45):35155-35168. https://doi.org/10.1074/jbc.M110.101212
He X, Li S, Fang X, Liao Y. TDCPP protects cardiomyocytes from hypoxia-reoxygenation injury induced apoptosis through mitigating calcium overload and promotion GSK-3beta phosphorylation. Regul Toxicol Pharmacol. 2018;92:39-45. https://doi.org/10.1016/j.yrtph.2017.11.005
Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol. 2003;4(7):552-565. https://doi.org/10.1038/nrm1150
Zhong J, He Y, Chen W, et al. Circulating microRNA-19a as a potential novel biomarker for diagnosis of acute myocardial infarction. Int J Mol Sci. 2014;15(11):20355-20364. https://doi.org/10.3390/ijms151120355
Diehl P, Fricke A, Sander L, et al. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res. 2012;93(4):633-644. https://doi.org/10.1093/cvr/cvs007
Ji L, Fu F, Zhang L, et al. Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress. Am J Physiol Endocrinol Metab. 2010;298(4):E871-E880. https://doi.org/10.1152/ajpendo.00623.2009
Liu LF, Liang Z, Lv ZR, et al. MicroRNA-15a/b are upregulated in response to myocardial ischemia/reperfusion injury. J Geriatr Cardiol. 2012;9(1):28-32. https://doi.org/10.3724/SP.J.1263.2012.00028
Yang Q, Yang K, Li A. microRNA-21 protects against ischemia-reperfusion and hypoxia-reperfusion-induced cardiocyte apoptosis via the phosphatase and tensin homolog/Akt-dependent mechanism. Mol Med Rep. 2014;9(6):2213-2220. https://doi.org/10.3892/mmr.2014.2068
Zhai C, Tang G, Peng L, et al. Inhibition of microRNA-1 attenuates hypoxia/re-oxygenation-induced apoptosis of cardiomyocytes by directly targeting Bcl-2 but not GADD45Beta. Am J Transl Res. 2015;7(10):1952-1962.
Aurora AB, Mahmoud AI, Luo X, et al. MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca(2)(+) overload and cell death. J Clin Invest. 2012;122(4):1222-1232. https://doi.org/10.1172/JCI59327
Dorn GN. Apoptotic and nonapoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res. 2009;81(3):465-473. https://doi.org/10.1093/cvr/cvn243
Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev. 2008;88(2):581-609. https://doi.org/10.1152/physrev.00024.2007
R K, R LAV, AR L, et al. SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway. Eur Heart J. 2012;33(9):1067-1075. https://doi.org/10.1093/eurheartj/ehs043
Conklin DJ, Guo Y, Nystoriak MA, et al. Transient receptor potential ankyrin-1 (TRPA1) channel contributes to myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2019;316(4):889-899. https://doi.org/10.1152/ajpheart.00106.2018.
Lu Y, Piplani H, McAllister SL, Hurt CM, Gross ER. Transient receptor potential ankyrin 1 activation within the cardiac myocyte limits ischemia-reperfusion injury in rodent. Anesthesiology. 2017;125(6):1171-1180. https://doi.org/10.1097/ALN.0000000000001377
Sun Z, Han J, Zhao W, et al. TRPV1 activation exacerbates hypoxia/reoxygenation-induced apoptosis in H9C2 cells via calcium overload and mitochondrial dysfunction. Int J Mol Sci. 2014;15:18362-18380. https://doi.org/10.3390/ijms151018362
Han L, Li J. Canonical transient receptor potential 3 channels in atrial fibrillation. Eur J Pharmacol. 2018;837:1-7. https://doi.org/10.1016/j.ejphar.2018.08.030
Fliegel L. The Na+/H+ exchanger isoform 1. Int J Biochem Cell Biol. 2005;37(1):33-37. https://doi.org/10.1016/j.biocel.2004.02.006
Allen DG, Xiao XH. Role of the cardiac Na+/H+ exchanger during ischemia and reperfusion. Cardiovasc Res. 2003;57(4):934-941.
Avkiran M. Protection of the ischaemic myocardium by Na+/H+ exchange inhibitors: potential mechanisms of action. Basic Res Cardiol. 2001;96(4):306-311.
Karmazyn M, Sawyer M, Fliegel L. The Na(+)/H(+) exchanger: a target for cardiac therapeutic intervention. Curr Drug Targets Cardiovasc Haematol Disord. 2005;5(4):323-335.
Sun G, Lu Y, Li Y, et al. miR-19a protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis via PTEN/PI3K/p-Akt pathway. Biosci Rep. 2017;37(6), https://doi.org/10.1042/BSR20170899